Company Overview - GRAIL, Inc. is a commercial-stage healthcare company focused on providing multi-cancer early detection testing and services [2]. Investigation Announcement - Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving GRAIL, Inc. [1]. Trial Results - On February 19, 2026, GRAIL announced results from its NHS-Galleri trial, which assessed annual multi-cancer screening using the Galleri test. The trial did not meet its primary endpoint, as a statistically significant reduction in Stage III-IV cancer was not observed [3]. Stock Market Reaction - Following the announcement of the trial results, GRAIL's stock price experienced a significant decline [3].

Core Viewpoint - A securities fraud class action lawsuit has been filed against Ultragenyx Pharmaceutical Inc. for allegedly making false and misleading statements regarding its drug setrusumab during the class period from August 3, 2023, to December 26, 2025 [2][4][6]. Group 1: Lawsuit Details - The lawsuit is filed in the United States District Court for the Northern District of California under the case name Bailey v. Ultragenyx Pharmaceutical Inc., et al, Case No. 3:26-cv-01097 [2]. - Investors have until April 6, 2026, to file for lead plaintiff status [2][6]. - The complaint alleges that Ultragenyx misrepresented the reliability of information regarding setrusumab's effects on Osteogenesis Imperfecta patients and downplayed the risks associated with the Phase III Orbit study [4][6]. Group 2: Allegations Against Ultragenyx - The lawsuit claims that Ultragenyx created a false impression of possessing reliable data on setrusumab while failing to disclose the risk of not achieving statistically significant results in the Phase III study [4]. - It is alleged that the company's optimism regarding the study's results was misplaced, as the Phase II results lacked a placebo control group, raising questions about the validity of the findings [4]. - Defendants' positive statements about the company's business and prospects were deemed materially misleading and lacking a reasonable basis [4]. Group 3: Investor Actions - Ultragenyx investors are encouraged to contact Kessler Topaz Meltzer & Check, LLP for recovery options at no cost [6][8]. - Investors can choose to seek lead plaintiff status or remain absent class members [5][8]. - The lead plaintiff will represent all class members in directing the litigation and is typically the investor or small group of investors with the largest financial interest [5][8].

Core Viewpoint - Fermi Inc. (NASDAQ: FRMI) is facing a securities class action lawsuit due to alleged misrepresentations regarding the demand for its Project Matador AI data center and the stability of its primary anchor tenant, which led to a significant stock price decline following the termination of a $150 million construction funding agreement [1]. Group 1: Allegations and Impact - The lawsuit claims that Fermi misrepresented the demand for its flagship Project Matador and the risks associated with its anchor tenant [1]. - On December 12, 2025, Fermi announced the termination of the $150 million Advance in Aid of Construction Agreement (AICA) by its first tenant, resulting in a nearly 34% drop in stock price [1]. - By the time the class action lawsuit commenced, Fermi's stock had fallen to as low as $8.59 per share, marking a 59% decline from its IPO price of $21.00 per share [1]. Group 2: Class Action Details - The class action seeks to represent purchasers of Fermi's common stock related to its October 2025 IPO and securities acquired between October 1, 2025, and December 11, 2025 [1]. - The complaint alleges that Fermi's IPO materials inflated the actual demand for Project Matador's capacity to attract higher valuations [1]. - The lawsuit highlights concealed risks regarding the reliance on a single tenant's funding commitment for the project's financing [1].

Core Viewpoint - BellRing Brands, Inc. (BRBR) is facing a securities class action lawsuit alleging that the company and its executives misled investors about the true drivers of its sales growth, which was reportedly inflated due to retailers hoarding inventory to avoid supply chain shortages [1][1]. Group 1: Allegations and Lawsuit Details - The lawsuit claims that BellRing's reported sales growth was not reflective of actual consumer demand but rather a result of temporary inventory stockpiling by key customers [1][1]. - The suit highlights that the misleading statements regarding sales growth led to a significant drop in share price, with a 33% decline on August 4, 2025, following disappointing financial results [1][1]. - The CFO of BellRing admitted that retailers were hoarding inventory during Q2 2025, which contributed to the inflated sales figures, yet downplayed the potential negative impact on future sales [1][1]. Group 2: Financial Impact and Market Reaction - Following the revelation of the inventory hoarding, BellRing's share price fell by $14.88, representing a 19% decrease after the Q2 2025 results were announced [1][1]. - The lawsuit suggests that once retailers felt confident that product shortages were resolved, they began to destock their inventory, leading to a foreseeable drop in BellRing's sales [1][1]. - The overall market reaction to the disclosures has been severe, with the company's stock experiencing significant volatility and losses attributed to the alleged misrepresentation of sales growth [1][1].

Core Viewpoint - Hagens Berman is investigating Varonis Systems, Inc. (NASDAQ: VRNS) over allegations of failing to disclose significant issues related to its transition to a Software-as-a-Service (SaaS) model, which has led to a substantial decline in revenue and stock value [1]. Group 1: Allegations and Lawsuit Details - The lawsuit claims that Varonis executives concealed renewal softness in its Federal vertical and legacy on-premises business while promoting a successful transition to SaaS [1]. - Following a disclosure on October 28, 2025, Varonis reported a 63.9% year-over-year decline in term license revenue and a reduced Annual Recurring Revenue (ARR) outlook, resulting in a 48% drop in stock price, equating to a loss of approximately $3.8 billion in market value [1]. - The investigation focuses on whether Varonis violated federal securities laws by failing to disclose the significant decline in renewals and the challenges in converting existing customers to the SaaS model [1]. Group 2: Financial Impact and Stock Performance - On the news of the revenue decline, Varonis shares plummeted from $63.00 to $32.34 in a single day, representing a nearly 50% loss in shareholder value [1]. - The company significantly reduced its Q4 revenue and full-year ARR guidance following the Q3 performance miss, indicating a serious impact on its financial outlook [1]. - The lawsuit alleges that Varonis misrepresented its ability to convert on-premises customers to SaaS, claiming strong retention and renewal rates, which were contradicted by the actual performance [1]. Group 3: Next Steps for Investors - Hagens Berman is advising investors who purchased VRNS shares during the class period from February 4, 2025, to October 28, 2025, and experienced substantial losses to contact the firm [1]. - The lead plaintiff deadline for the pending lawsuit is set for March 9, 2026, urging affected investors to take action [1].

NEW YORK, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against NuScale Power Corporation (NYSE: SMR) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired NuScale securities between May 13, 2025 and November 10, 2025, both ...

Core Viewpoint - Enphase Energy, Inc. is facing a class action securities lawsuit due to alleged securities fraud that affected investors between April 22, 2025, and October 28, 2025 [1] Group 1: Lawsuit Details - The lawsuit claims that Enphase and certain executives failed to disclose material information, violating federal securities laws [1] - Allegations include overstating the company's ability to manage channel inventory and offset impacts from the termination of the Residential Clean Energy Credit [1] - The case is identified as Tripathi v. Enphase Energy, Inc., No. 26-cv-01380 [1] Group 2: Investor Actions - Investors who suffered losses during the specified period have until April 20, 2026, to request appointment as lead plaintiff [1] - Participation in any recovery does not require serving as a lead plaintiff [1] Group 3: Law Firm Background - Kahn Swick & Foti, LLC is a prominent boutique securities litigation law firm, ranked among the top 10 firms nationally based on total settlement value [1] - The firm represents a variety of clients, including public and private institutional investors, in seeking recoveries for investment losses due to corporate fraud [1]

Core Viewpoint - Ostin Technology Group Co., Ltd. is facing a class action lawsuit due to allegations of fraudulent activities during a specific class period, which has significantly impacted its stock price and investor confidence [1][4][5]. Group 1: Class Action Details - The class action lawsuit is on behalf of investors who purchased Ostin securities between May 11, 2025, and June 26, 2025, with a deadline for filing a lead plaintiff motion set for April 217, 2026 [1]. - The lawsuit claims that Ostin's executives engaged in a fraudulent scheme to manipulate the stock price and trading volume through misleading statements and coordinated sell-offs [4][5]. Group 2: Allegations of Fraud - The lawsuit alleges that starting in April 2025, a fraudulent sequence of securities offerings was orchestrated to transfer the majority of Ostin shares to at least 15 co-conspirators at significantly undervalued prices [4]. - It is claimed that these offerings were part of a broader scheme to artificially inflate the stock price through deceptive marketing tactics, including impersonating financial professionals [4]. Group 3: Impact on Stock Price - On June 26, 2025, a coordinated sell-off led to a dramatic decline in Ostin's stock price, which fell by more than 94% in a single trading session [5]. Group 4: Company Overview - Ostin Technology specializes in designing, developing, and manufacturing thin-film transistor liquid crystal display (TFT-LCD) modules and polarizers [3].

Core Viewpoint - PayPal Holdings, Inc. is facing a class action lawsuit due to allegations of misleading investors regarding its revenue outlook and growth potential during the Class Period from February 25, 2025, to February 2, 2026 [1] Group 1: Class Action Lawsuit Details - The lawsuit, Goodman v. PayPal Holdings, Inc., claims that PayPal and certain executives violated the Securities Exchange Act of 1934 [1] - Investors who suffered substantial losses during the Class Period have until April 20, 2026, to seek appointment as lead plaintiff [1] - The lawsuit alleges that PayPal's optimistic growth plans were unrealistic and that the company minimized risks associated with macroeconomic fluctuations [1] Group 2: Financial Performance and Impact - On February 3, 2026, PayPal announced disappointing financial results for Q4 and full fiscal year 2025, including a decline in Branded Checkout performance and the withdrawal of its 2027 financial targets [1] - The announcement led to a more than 20% drop in PayPal's stock price [1] - The company attributed its poor performance to macroeconomic factors, competition, and operational issues across all regions [1] Group 3: Lead Plaintiff Process - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased PayPal common stock during the Class Period to seek lead plaintiff status [1] - The lead plaintiff represents the interests of all class members and can select a law firm for litigation [1] - An investor's potential recovery is not contingent upon serving as lead plaintiff [1] Group 4: About Robbins Geller - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder rights litigation, having recovered over $916 million for investors in 2025 [1] - The firm has a strong track record, recovering $8.4 billion for investors over the past five years [1] - Robbins Geller is one of the largest plaintiffs' firms globally, with a history of significant securities class action recoveries [1]

Core Viewpoint - A class action lawsuit has been filed against Varonis Systems, Inc. on behalf of investors who acquired Varonis securities during the specified class period, highlighting concerns over the company's financial disclosures and performance [1][3]. Group 1: Lawsuit Details - The lawsuit is initiated by Berger Montague PC, representing investors who purchased Varonis securities from February 4, 2025, to October 28, 2025 [1][2]. - Investors became aware of significant issues regarding customer renewals and conversions when Varonis announced its Q3 2025 financial results on October 28, 2025, revealing a substantial annual recurring revenue (ARR) miss and a reduction in guidance for the full fiscal year 2025 [3]. Group 2: Financial Impact - Following the announcement of disappointing financial results, Varonis' stock price plummeted from $63.00 per share on October 28, 2025, to $32.34 per share on October 29, 2025, marking a decline of $30.66 per share, or over 48% in just one day [4]. - The company attributed the poor performance to weaker than expected renewals and conversions in its subscription business, alongside announcing the end-of-life for its self-hosted solution and a 5% reduction in headcount [3].